• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Variant Analysis of SARS-CoV-2 Genomes from Belgian Military Personnel Engaged in Overseas Missions and Operations

tetano

Editor, Senior Moderator
Viruses


. 2021 Jul 13;13(7):1359.
doi: 10.3390/v13071359.
Variant Analysis of SARS-CoV-2 Genomes from Belgian Military Personnel Engaged in Overseas Missions and Operations


Jean-Paul Pirnay[SUP] 1 [/SUP], Philippe Selhorst[SUP] 2 [/SUP], Samuel L Hong[SUP] 3 [/SUP], Christel Cochez[SUP] 1 [/SUP], Barney Potter[SUP] 3 [/SUP], Piet Maes[SUP] 3 [/SUP], Mauro Petrillo[SUP] 4 [/SUP], Gytis Dudas[SUP] 5 6 [/SUP], Vincent Claes[SUP] 7 [/SUP], Yolien Van der Beken[SUP] 7 [/SUP], Gilbert Verbeken[SUP] 1 [/SUP], Julie Degueldre[SUP] 7 [/SUP], Simon Dellicour[SUP] 3 8 [/SUP], Lize Cuypers[SUP] 9 [/SUP], France T'Sas[SUP] 7 [/SUP], Guy Van den Eede[SUP] 10 [/SUP], Bruno Verhasselt[SUP] 11 [/SUP], Wouter Weuts[SUP] 12 [/SUP], Cedric Smets[SUP] 13 [/SUP], Jan Mertens[SUP] 14 [/SUP], Philippe Geeraerts[SUP] 14 [/SUP], Kevin K Ariën[SUP] 15 16 [/SUP], Emmanuel André[SUP] 9 17 [/SUP], Pierre Neirinckx[SUP] 14 [/SUP], Patrick Soentjens[SUP] 18 19 [/SUP], Guy Baele[SUP] 3 [/SUP]



Affiliations

Abstract

More than a year after the first identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the causative agent of the 2019 coronavirus disease (COVID-19) in China, the emergence and spread of genomic variants of this virus through travel raise concerns regarding the introduction of lineages in previously unaffected regions, requiring adequate containment strategies. Concomitantly, such introductions fuel worries about a possible increase in transmissibility and disease severity, as well as a possible decrease in vaccine efficacy. Military personnel are frequently deployed on missions around the world. As part of a COVID-19 risk mitigation strategy, Belgian Armed Forces that engaged in missions and operations abroad were screened (7683 RT-qPCR tests), pre- and post-mission, for the presence of SARS-CoV-2, including the identification of viral lineages. Nine distinct viral genotypes were identified in soldiers returning from operations in Niger, the Democratic Republic of the Congo, Afghanistan, and Mali. The SARS-CoV-2 variants belonged to major clades 19B, 20A, and 20B (Nextstrain nomenclature), and included "variant of interest" B.1.525, "variant under monitoring" A.27, as well as lineages B.1.214, B.1, B.1.1.254, and A (pangolin nomenclature), some of which are internationally monitored due to the specific mutations they harbor. Through contact tracing and phylogenetic analysis, we show that isolation and testing policies implemented by the Belgian military command appear to have been successful in containing the influx and transmission of these distinct SARS-CoV-2 variants into military and civilian populations.

Keywords: COVID-19; SARS-CoV-2; genomic epidemiology; military; outbreak; variants.
 
Back
Top Bottom